Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
366.80
+1.29 (0.35%)
At close: Sep 24, 2025
Sichuan Biokin Pharmaceutical Company Description
Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and supply of biomedicine in the fields of antibody drug conjugate, guidance navigation and control, and antibody radionuclide conjugate in China and internationally.
It offers anesthesia, parenteral nutrition, anti-infectives, pediatrics, and traditional Chinese medicines.
The company was founded in 1996 and is headquartered in Chengdu, China.
Sichuan Biokin Pharmaceutical Co.,Ltd.
Country | China |
Founded | 1996 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2,521 |
CEO | Yi Zhu |
Contact Details
Address: Block B, Gaoxin International Plaza Chengdu China | |
Phone | 86 28 8518 3639 |
Website | baili-pharm.com |
Stock Details
Ticker Symbol | 688506 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Yi Zhu | Chairman, GM and Chief Scientific Officer |
Suya Zhang | Chief Financial Officer, Executive Deputy GM, Accounting Supervisor and Director |
Jian Kang | Deputy GM and Director |
Yingge Chen | Board Secretary |